Abstract
Keywords
References
Lavigne JV, Lebailly SA, Hopkins J, Gouze KR, Binns HJ. The prevalence of ADHD, odd, depression, and anxiety in a community sample of 4-year-olds. J Clin Child Adolesc Psychol. 2009;38:315–328.
Lavigne JV, Gibbons RD, Christoffel KK, Arend R, Rosenbaum D, Binns H. Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry.1996;35:204–214.
Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: A community perspective. J Am Acad Child Adolesc Psychiatry. 2000;39:975–984; discussion 984–994.
Keenan K, Wakschlag LS. More than the terrible twos: The nature and severity of behavior problems in clinic-referred preschool children. J Abnorm Child Psychol. 2000;28:33–46.
Egger HL, Angold A. Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology.J Child Psychol Psychiatry. 2006;47:313–337.
McDonnell MA, Glod C. Prevalence of psychopathology in preschool-age children. J Child Adolesc Psychiatr Nurs. 2003;16:141–152.
May DE, Kratochvil CJ. Attention-deficit hyperactivity disorder:recent advances in paediatric pharmacotherapy. Drugs.2010;70:15–40.
Angold A, Egger HL. Preschool psychopathology: Lessons for the lifespan. J Child Psychol Psychiatry. 2007;48:961–966.
Lahey BB, Pelham WE, Loney J, Kipp H, Ehrhardt A, Lee SS. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4–6 years of age. Am J Psychiatry. 2004;161:2014–2020.
Baker BL, Neece CL, Fenning RM, Crnic KA, Blacher J. Mental disorders in five-year-old children with or without developmental delay: Focus on ADHD. J Clin Child Adolesc Psychol. 2010;39:492–505.
Chung J, Tchaconas A, Meryash D, Adesman A. Treatment of attention-deficit/hyperactivity disorder in preschool-age children: Child and adolescent psychiatrists’ adherence to clinical practice guidelines. J Child Adolesc Psychopharmacol.2016;26:335–343.
Laforett DR, Murray DW, Kollins SH. Psychosocial treatments for preschool-aged children with attention-deficit hyperactivity disorder. Dev Disabil Res Rev. 2008;14:300–310.
Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1284–1293.
Dreyer AS, O’Laughlin L, Moore J, Milam Z. Parental adherence to clinical recommendations in an ADHD evaluation clinic. J Clin Psychol. 2010;66:1101–1120.
Gleason MM, Egger HL, Emslie GJ, Greenhill LL, Kowatch RA, Lieberman AF, et al. Psychopharmacological treatment for very young children: Contexts and guidelines. J Am Acad Child Adolesc Psychiatry. 2007;46:1532–1572.
Shelton TL, Barkley RA, Crosswait C, Moorehouse M, Fletcher K, Barrett S, et al. Multimethod psychoeducational intervention for preschool children with disruptive behavior: Two year post-treatment follow-up. J Abnorm Child Psychol.2000;28:253–266.
Pelsser LM, Frankena K, Toorman J, Savelkoul HF, Dubois AE, Pereira RR, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (inca study): A randomised controlled trial. Lancet.2011;377:494–503.
Ghuman JK. Restricted elimination diet for ADHD: The in case study. Lancet. 2011;377:446–448.
Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170:275–289.
Kratochvil CJ, Vaughan BS, Stoner JA, Daughton JM, Lubberstedt BD, Murray DW, et al. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics. 2011;127:e862–e868.
Kohn MR, Tsang TW, Clarke SD. Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder. Clin Med Insights Pediatr. 2012;6:95–162.
Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, et al. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007–1022.
Hart KC, Ros R, Gonzalez V, Graziano PA. Parent perceptions of medication treatment for preschool children with ADHD. Child Psychiatry Hum Dev. 2018;49:155–162.
Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhill LL, Swanson JM, et al. Methylphenidate effects on functional outcomes in the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol. 2007;17:581–592.
Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers.JAMA. 2000;283:1025–1030.
Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894–921.
Bourgeois FT, Kim JM, Mandl KD. Premarket safety and efficacy studies for ADHD medications in children. PLoS One.2014;9:e102249.
Sonnack M, Brenneman A. Treatment strategies for ADHD in preschool and school-age children. JAAPA. 2014;27:22–26.
Handen BL, Feldman HM, Lurier A, Murray PJ. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry. 1999;38:805–812.
Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, et al. Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with attentiondeficit/ hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol. 2007;17:593–604.
Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, et al. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1294–1303.
Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, et al. Comorbidity moderates response to methylphenidate in the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmacol.2007;17:563–580.
Wigal SB, Gupta S, Greenhill L, Posner K, Lerner M, Steinhoff K, et al. Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17:153–164.
Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40:180–187.
Ghuman JK, Byreddy S, Ghuman HS. Methylphenidate transdermal system in preschool children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21:495–498.
Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, et al. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol. 2009;19:329–339.
Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry. 2006;45:1304–1313.
Barkley RA. The effects of methylphenidate on the interactions of preschool adhd children with their mothers. J Am Acad Child Adolesc Psychiatry. 1988;27:336–341.
Ghuman JK, Ginsburg GS, Subramaniam G, Ghuman HS, Kau ASM, Riddle MA. Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: Clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry. 2001;40:516–524.
Chouinard G, Annable L, Bradwejn J. An early phase II clinical trial of tomoxetine (ly139603) in the treatment of newly admitted depressed patients. Psychopharmacology (Berl).1984;83:126–128.
Zerbe RL, Rowe H, Enas GG, Wong D, Farid N, Lemberger L. Clinical pharmacology of tomoxetine, a potential antidepressant. J Pharmacol Exp Ther. 1985;232:139–143.
Upadhyaya H, Kratochvil C, Ghuman J, Camporeale A, Lipsius S, D’Souza D, et al. Efficacy and safety extrapolation analyses for atomoxetine in young children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2015;25:799–809.
Ghuman JK, Aman MG, Ghuman HS, Reichenbacher T, Gelenberg A, Wright W, et al. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19:155–166.
Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML, March JS, Kollins SH, Murray DW, et al. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17:175–185.
Rosch KS, Crocetti D, Hirabayashi K, Denckla MB, Mostofsky SH, Mahone EM. Reduced subcortical volumes among preschool-age girls and boys with ADHD. Psychiatry Res. 2018;271:67–74.
Lahey BB, Pelham WE, Stein MA, Loney J, Trapani C, Nugent K, et al. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry. 1998;37:695–702.
Kaplan A, Adesman A. Clinical diagnosis and management of attention deficit hyperactivity disorder in preschool children.Curr Opin Pediatr. 2011;23:684–692.
Ghuman JK, Arnold LE, Anthony BJ. Psychopharmacological and other treatments in preschool children with attentiondeficit/hyperactivity disorder: Current evidence and practice. J Child Adolesc Psychopharmacol. 2008;18:413–447.
Dulcan MK, Benson RS. Aacap official action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry. 1997;36:1311–1317.
van Brunt DL, Johnston JA, Ye W, Pohl GM, Sun PJ, Sterling KL, et al. Predictors of selecting atomoxetine therapy for children with attention-deficit-hyperactivity disorder. Pharmacotherapy. 2005;25:1541–1549.
Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: A randomized, double-blind comparison trial. Aust N Z J Psychiatry. 2007;41:222–230.
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.